Literature DB >> 29596576

The end for individualized dosing in IVF ovarian stimulation? Reply to letters-to-the-editor regarding the OPTIMIST papers.

T C van Tilborg1, H L Torrance1, S C Oudshoorn1, M J C Eijkemans2, B W Mol3,4, F J M Broekmans1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29596576     DOI： 10.1093/humrep/dey064

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  2 in total

Review 1.  Management Strategies for POSEIDON Groups 3 and 4.

Authors:  Thor Haahr; Carlos Dosouto; Carlo Alviggi; Sandro C Esteves; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-11       Impact factor: 5.555

2.  Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders.

Authors:  Jori A Leijdekkers; Helen L Torrance; Nienke E Schouten; Theodora C van Tilborg; Simone C Oudshoorn; Ben Willem J Mol; Marinus J C Eijkemans; Frank J M Broekmans
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.